You are searching for: hsa04660

---

T99149 Target Info	Target Name	HUMAN ERK activator kinase 2 (MEK2)
	Target type	. Target
	Disease	Metastatic melanoma; Neurofibromatosis type 1;
	Drugs	Trametinib	Drug Info

T85529 Target Info	Target Name	T-cell-specific surface glycoprotein CD28 (CD28)
	Target type	Successful Target
	Disease	Kidney transplant rejection; Heart transplant rejection;
	Drugs	Belatacept	Drug Info

T35940 Target Info	Target Name	ERK activator kinase 1 (MEK1)
	Target type	Clinical trial Target
	Disease	Melanoma; Thyroid cancer;
	Drugs	Selumetinib	Drug Info

T70977 Target Info	Target Name	Glycogen synthase kinase-3 beta (GSK-3B)
	Target type	Clinical trial Target
	Disease	Myotonic dystrophy; Acute myeloid leukaemia;
	Drugs	AMO-02	Drug Info

T67619 Target Info	Target Name	RAC-alpha serine/threonine-protein kinase (AKT1)
	Target type	Successful Target
	Disease	Triple negative breast cancer; Colorectal cancer;
	Drugs	Capivasertib	Drug Info

T89055 Target Info	Target Name	ERK activator kinase 2 (MEK2)
	Target type	Clinical trial Target
	Disease	Melanoma; Thyroid cancer;
	Drugs	Selumetinib	Drug Info

T58970 Target Info	Target Name	Extracellular signal-regulated kinase 2 (ERK2)
	Target type	Clinical trial Target
	Disease	Melanoma; Artery stenosis;
	Drugs	BVD-523	Drug Info

T78429 Target Info	Target Name	Inhibitor of nuclear factor kappa-B kinase beta (IKKB)
	Target type	Clinical trial Target
	Disease	Acute lymphoblastic leukaemia; Alzheimer disease;
	Drugs	Arsenic trioxide	Drug Info

T43115 Target Info	Target Name	Leukocyte common antigen (PTPRC)
	Target type	Clinical trial Target
	Disease	Bone marrow transplantation; Acute myeloid leukaemia;
	Drugs	Iomab-B	Drug Info

T23995 Target Info	Target Name	Protein kinase C theta (PRKCQ)
	Target type	Clinical trial Target
	Disease	Renal transplantation; Inflammation;
	Drugs	Sotrastaurin acetate	Drug Info

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.